shows demographic summary statistics across campaigns and treatments. We observe a total of 662,713 unique visitors to the site. We only observe demographic information for 310,210 of these observations, and these visitors are more likely to submit an application. The first column of Table A1 shows mean demographic characteristics for the control group across the three campaigns for the subsample the submits demographic information. The average visitor is slightly more than 40 years old, has 1.6 family members and is slightly more likely to be female than male. Figure A1 displays the distribution of users in the experiment by self-reported age and gender. Most users are in the range of 20-60 years old, and both genders seem well represented across age groups.
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The remaining columns of Table A1 conduct randomization tests to confirm that validity of the experiment. In particular, the columns show the results of regressions of the different demographic variables on an indicator for whether the visitor was assigned Treatment B or Treatment C. The table shows no correlation between treatment assignment and the demographics, confirming the randomized nature of the experiment. Table A2 looks at whether the demographic composition and behavior of visitors to the site changes as we approach the deadlines (using data pooled across treatments and campaigns). The table shows that the average visitor tends to be older and has a higher likelihood of submitting an application as we approach the enrollment deadline, although the effects are not particularly strong.
B. Treatment Effect Heterogeneity
We begin our analysis by simply comparing the outcome across treatment and control at the aggregate level. That is we pool the entire sample across demographic observables and days, and simply compare those in treatments with a Table A3 presents the mean conversion rates for these scenarios. The control group had a mean conversion rate of the sample period of 2.63 percent. Treatment group B-customers who saw the countdown messaging with reference to the penalty of signing up beyond the deadline-had a mean conversion rate of 2.62 percent. Treatment Ccustomers who saw the countdown but with relatively more benign messaginghad a mean conversion rate of 2.70 percent. While the treatments do appear to have had a small impact, the differences are both small in magnitude and treatment B is statistically insignificant while treatment C is significant at the 10 percent level. We next turn to the impact of messaging over time. While there are many reasons to consider how the types of customers shopping and the ways in which messaging might affect their behavior might change over time, we are particularly interested in the time dimension because (i) the treatment messaging emphasized time to the deadline using a countdown clock and (ii) given some of the difficulties with HealthCare.gov there were repeated changes to the actual deadline to get coverage in order to avoid paying the individual penalty. These features could certainly have led to many different responses depending on procrastination, beliefs about enforcement, etc. We do not explicitly model this but rather focus on whether there are differences in the impact of treatments early in the rollout from 10 to 7 days from the relevant deadline compared to the closer dates from 6 to 4 days prior to the deadline. The second panel of Table A3 shows the differential impact of treatments B and C in each of these periods. We first note that conversion rates were lower even in the control group in the early period, potentially reflecting some search behavior or procrastination. In the early period the deadline messaging appears, if anything, to have reduced the conversion rate, although the effects are small and not significantly different from zero. On the other hand, as the deadline drew near we see conversion rates rise in the control group but also a significant increase in the impact of treatment C on conversions. While still relatively small, 0.16 percentage points, the effect is positive and significant at the 5 percent level. These differences underscore the importance not only of the ability to try new customer experiences but to understand how they might impact different customers differently. In this case, the optimal strategy would appear to be avoiding messaging with a countdown until close to the actual deadline itself. We return to the optimal combination below.
In addition to time targeting, customers can be targeted based on potentially detailed demographic information. In the setting we study, this can occur if customers search for plan options and supply demographic detail. More generally, when customers arrive at web pages they bring cookies from prior sites visited and firms can potentially predict demographic details based on this information to target messaging (or target based on website history directly). In either case, we are interested in whether the impact of the different treatments varies along the dimension of easily observed demographics. To study this question we estimate the impact of each treatment within demographic groups defined by age (above or below the median age of 40), gender and single versus family.
The results, in the third panel of Table A3 demonstrate that there are some groups for which the impact of different messaging seems to be both economically meaningful and statistically significant. We find, for example, that both men and women under 40 who are single have a significant positive response to treatment B and C relative to control. The impact is 0.35 and 0.42 percentage points respectively or a 6 percent and 5 percent increase in conversion rates due to deadline messaging. The deadline messaging does not have a statistically significant impact among other demographic groups, families overall and younger single populations.
Finally, we study variation in the impact of messaging based on geography. In this case, we study the differential impact of the treatments across states. States are a natural segmentation unit in our setting for a number of reasons: insurance markets are regulated at the state level, plan offerings are generally made at the state level and political sentiment vis a vis health reform also varies across states (e.g. red versus blue states). In this study we do not explore these mechanisms explicitly. Instead, we estimate the variation across states by allowing a differential treatment effect for each message across each state, as described in our estimation approach. Figure A2 shows the distribution of these treatment effects across the various states in our sample, controlling for individual specific characteristics like age, gender, and family size. The upper figure is the distribution for the "pooled" treatment effect, which combines observations experiencing both treatments B and C, while the bottom histograms separate the two effects. While the majority of states have a near zero response to the deadline messaging, there are a number of states (approximately 20 percent) for whom the treatment increases or decreases the conversion rate by more than 1 percentage point (note that this is very large in comparison to a 0.3 to 0.4 percentage point treatment effect for specific demographic groups, as discussed above), with the effect being as large as 3 to 4 percentage points for some outlying states.
C. Bias Adjustment
Let i denote the day × demographic group × state × treatment cells and g denote the "groups" at which we allow for heterogeneous treatment effects. Using the experiment, we are able to recover estimates of the treatment effectβ g for each group g. We would like to recover the conversation rate from the "optimal" targeting scheme, which we define as the scheme that assigns treatment to a group if and only if it increases conversions relative to the control. This is given by r = g s g max{β g , 0}, where s g is the fraction of visitors in demographic group g.
By the Central Limit Theorem, we know the treatment effect estimates are distributed
where n g is the number of observations in group g and σ β is the standard deviation of the estimate. It is convenient to rewrite the estimated treatment effect as the sum of the true effect and a normally distributed error term,β g = β g + βg , where βg ∼ N (0,
Consider the adjusted estimator r that assigns the estimated treatment minus a bias-adjustment term to a group if and only if the estimated treatment effect is positive:
.
is the term that adjusts the estimate. The expected value of this object is given by
We can further simply the expectation term to be The probability term can be simplified to be
Putting these pieces together gives us
There are a few things to note about our estimator compared to the true effect of optimal targeting given by g max {β g , 0} = g 1(β g > 0)β g . First, our estimator is downward biased:
This can be observed by comparing Φ( βg σ βg / √ ng )β g to 1(β g > 0)β g over the negative and positive ranges of β g . When β g is negative, Φ(
and therefore the term on the left hand side of the inequality is smaller. When β g is positive, Φ( βg σ βg / √ ng )β g < 1(β g > 0)β g = β g and the term on the left had side is smaller as well.
Second, the estimator is consistent in the sense that this bias goes to zero for large n g . This follows from the fact that Φ( βg σ βg / √ ng ) converges to 1(β g > 0) for large enough n g .
Third, at least in our setting, we have conducted Monte Carlo simulations that suggest that bias is small. In particular, we've conducted a Monte Carlo with the following parameters:
• Number of demographic groups: 10
• Observations per demographic group: 50
• Conversion rate: Control is 50 percent: Group-specific treatment effect is draw from uniform distribution with 0-100 percent support. This means that targeting raises the conversion rate by approximately 12.5 percentage points.
• Number of Monte Carlos runs: 10,000
Panel A of Figure A3 shows a histogram of the estimated "lift" or increase in conversion rate when the estimates are unadjusted for this source of bias. Figure A3 . Monte Carlo Simulations
Adjusting for this source of bias when there are two treatment arms is conceptually similar. Let β g be the estimated effect of Treatment B and γ g be the estimated effect of Treatment C. With two treatments, the adjusted conversion rate from optimal targeting is given by
We have not been able to derive analytical expressions for the conditional expectation terms E[ βg | β g > max{ γ g , 0}] and E[ γg | γ g > max{ β g , 0}]. We therefore estimate these terms by numerically integrating over the distributions of β g and γ g , as described below.
D. Bootstrap Standard Errors
To assess the impact of each treatment and targeting rule we estimate bootstrapped standard errors. While there are a number of general advantages, we are particularly interested in estimating bootstrapped standard errors in our setting given the potential for spurious findings when we study heterogeneity in the treatment effect. To do so we first divide our population of the control and treatment group into cells (with "cells" in our case referring to the demographic, time, or geographic-specific groups that we are interested in analyzing and targeting). We then apply a block bootstrap approach at the cell level and draw entire clusters with replacement 500 times. We then estimate the maximum treatment effect for each cell in each sample, and adjust this estimate given the level of noise in the sample and heterogeneity in the model of interest using numerical simulation. We repeat this process for all 500 bootstrap samples, forming a distribution of estimated treatment effects which yields a 95 % confidence interval.
Specifically, the steps of the bootstrap procedure to construct a confidence interval for our adjusted optimal targeting treatment effect, are: 1) Draw a sample from our population, with replacement, stratifying at the cell-level of targeting, g.
2) Estimate the maximum treatment effect for each cell (aka each targeted group),β g within the sample.
3) For each cell group and treatment effect estimate, simulate 300 draws from a distribution ∼ N (β g , σ 2 β ). Use these draws to numerically calculate P(β g > 0) and E β g |β g > 0 .
4) Using the probability and expected value obtained from step 3, calculate the adjusted treatment effectβ g = P(β g > 0)E β g |β g > 0 .
5) Take the weighted average ofβ g over all targeted groups to recover overall average treatment effect:r * = g s g 1( β g > 0)β g This process is repeated 500 times to create a distribution ofr * , which is then used to calculate a 95 percent CI. When we allow for heterogeneity this procedure accounts for potentially spurious findings in small cells flexibly. Suppose, for example, that we were spuriously finding large effects in only a small number of cells and these biased our main findings upwards. When we estimate bootstrapped standard errors those cells will be excluded for a number of runs and, therefore, we could find lower bound estimates without those cells that would be close to the control group.
